Home | Industry Information | Business News | Browse by Publication | B | BT Catalyst

PPD of Wilmington has sold to Takeda Pharmaceutical Co. of Osaka, Japan, the development and marketing rights to dipeptidyl peptidase IV (DPP4) inhibitors being tested for the treatment of type 2 diabetes, for $15 million plus future sums based on sales milestones and royalties.(COLLABORATIONS AND ACQUISITIONS)

Publication: BT Catalyst
Publication Date: 01-SEP-05
Format: Online - approximately 77 words
Delivery: Immediate Online Access

Article Excerpt
PPD of Wilmington has sold to Takeda Pharmaceutical Co. of...

Read this article now - Try Goliath Business News - FREE!   
You can view this article PLUS...

  • Over 5 million business articles
  • Hundreds of the most trusted magazines, newswires, and journals (see list)
  • Premium business information that is timely and relevant
  • Unlimited Access

Now for a Limited Time, try Goliath Business News - Free for 7 Days!
Tell Me More   Terms and Conditions

Purchase this article for $4.95

Already a subscriber? Log in to view full article



More articles from BT Catalyst
Novozymes North America.(AWARDS), September 01, 2005
Institute for Science Learning.(AWARDS), September 01, 2005
Zen-Bio of Research Triangle Park received a 24-month $961,578 Phase I..., September 01, 2005
Skin Science Institute of Durham received $409,224 from the National I..., September 01, 2005
Salem College of Winston-Salem received a $36,861 Regional Development..., September 01, 2005

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.